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Abstract
Objective: Occurrences	of	early-life	stress	(ELS)	are	associated	with	the	severity	of	
psychotic	symptoms	and	working	memory	(WM)	deficits	in	patients	with	psychosis	
(PSY).	This	 study	 investigated	potential	mediation	 roles	of	WM	behavioral	perfor-
mance and glutamate concentrations in prefrontal brain regions on the association 
between	ELS	and	psychotic	symptom	severity	in	PSY.
Method: Forty-seven	patients	with	PSY	(established	schizophrenia,	n = 30; bipolar 
disorder,	n	 =	17)	 completed	measures	of	 psychotic	 symptom	 severity.	 In	 addition,	
data	 on	ELS	 and	WM	performance	were	 collected	 in	 both	patients	with	PSY	 and	
healthy	controls	(HC;	n	=	41).	Resting-state	glutamate	concentrations	in	the	bilateral	
dorsolateral	prefrontal	cortex	(DLPFC)	and	anterior	cingulate	cortex	(ACC)	were	also	
assessed	with	proton	magnetic	resonance	spectroscopy	for	both	PSY	and	HC	groups.	
t	tests,	analyses	of	variance,	and	regression	analyses	were	utilized.
Results: Participants	 with	 PSY	 reported	 significantly	 more	 ELS	 occurrences	 and	
showed	poorer	WM	performance	than	HC.	Furthermore,	 individuals	with	PSY	dis-
played	lower	glutamate	concentrations	in	the	left	DLPFC	than	HC.	Neither	ELS	nor	
WM	performance	were	predictive	of	severity	of	psychotic	symptoms	in	participants	
with	PSY.	However,	we	found	a	significant	negative	correlation	between	glutamate	
concentrations	in	the	left	DLPFC	and	ELS	occurrence	in	HC	only.
Conclusion: In	individuals	with	PSY,	the	current	study	found	no	evidence	that	the	as-
sociation	between	ELS	and	psychotic	symptoms	is	mediated	by	WM	performance	or	
prefrontal	glutamate	concentrations.	In	HC,	the	association	between	ELS	experience	
and	glutamate	concentrations	may	indicate	a	neurometabolite	effect	of	ELS	that	is	
independent of an illness effect in psychosis.
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SIGNIFIC ANT OUTCOMES
Our findings of reduced glutamate concentrations in the left dorso-
lateral prefrontal cortex and poorer working memory performance 
in	patients	with	psychosis	(including	both	schizophrenia	and	bipolar	
disorder)	provide	evidence	for	illness-related	changes.
The significant relationship between early-life stress experience 
and glutamate concentrations in the left dorsolateral prefrontal cor-
tex in healthy controls indicates preliminary evidence for general 
neurobiological	effect	of	ELS.
LIMITATIONS
The early-life stress measure used in this study does not directly ask 
participants about abusive and neglectful experiences during child-
hood although it is known that such experiences are highly prevalent 
in individuals with a psychotic disorder. This may account for the 
lack of a relationship between early-life stress occurrences and psy-
chotic	symptom	severity	in	our	findings.	However,	it	is	also	known	
that other environmental risk factors are implicated in the onset and 
severity of psychosis.
Due	to	 the	relatively	small	 sample,	our	analyses	were	not	sen-
sitive	 to	 weaker	 associations	 among	 early-life	 stress	 occurrences,	
working	memory	performance,	glutamate	concentrations,	and	psy-
chotic symptom severity.
1  | INTRODUC TION
Psychotic disorders are debilitating conditions that are primarily 
characterized	 by	 positive	 symptoms	 (including	 delusions,	 halluci-
nations,	 and	 disorganized	 thoughts),	 negative	 symptoms	 (such	 as	
avolition,	 alogia,	 or	 apathy),	 and	 cognitive	 deficits	 (such	 as	 social	
cognition	and	working	memory	impairments).	The	latter	can	occur	
prior to the diagnosis of a psychotic disorder and can worsen with 
illness	 progression	 (Fusar-Poli	 et	 al.,	 2010;	MacDonald	 &	 Schulz,	
2009).	Cognitive	deficits	are	widely	considered	 to	be	core	symp-
toms	of	 schizophrenia	 (SZ;	Gold,	2004)	and	bipolar	disorder	 (BD;	
Bortolato,	Miskowiak,	Köhler,	Vieta,	&	Carvalho,	2015;	Martinez-
Aran	 &	 Vieta,	 2015)	 and	 are	 also	 associated	 with	 reductions	 in	
working memory performance. Working memory deficits are one 
of the main neurocognitive impairments found in subjects with 
first-episode	 psychosis	 (Kim	 et	 al.,	 2011;	 Seidman,	 2010)	 and	 in	
patients	 at	 the	 established	 stage	 (Genevsky,	 Garrett,	 Alexander,	
&	 Vinogradov,	 2010).	 Deficits	 in	working	memory	 are	 important	
given the role of working memory in information retention and 
manipulation in order to perform abilities such as speech and 
multitasking	 (Vöhringer	 et	 al.,	 2013)	 and	 involve	 the	 recruitment	
of	 the	 dorsolateral	 prefrontal	 cortex	 (DLPFC;	Glahn	 et	 al.,	 2005;	
Jalbrzikowski	 et	 al.,	 2018;	 Roberts,	 Libby,	 Inhoff,	 &	 Ranganath,	
2018).	Furthermore,	working	memory	deficits	are	associated	with	
impaired daily functioning in patients with a psychotic disorder 
(Vesterager	et	al.,	2012).
Epidemiological and clinical studies have also consistently re-
ported the impact of stress-related environmental risk factors on 
the	 severity	of	psychotic	 symptoms	 in	patients	with	SZ	and	BD,	
such	as	early-life	stress	(ELS)	which	includes	physical	abuse,	phys-
ical	neglect,	emotional	abuse,	emotional	neglect,	sexual	abuse	and	
household	 dysfunction	 (Bechdolf	 et	 al.,	 2010;	 Day	 et	 al.,	 1987;	
Gershon,	Johnson,	&	Miller,	2013;	Holtzman	et	al.,	2013;	Lataster,	
Myin-Germeys,	 Lieb,	Wittchen,	 &	 Os,	 2012;	 Mayo	 et	 al.,	 2017;	
Os,	Kenis,	&	Rutten,	2010;	Shannon	et	al.,	2011;	Thompson	et	al.,	
2009;	 Üçok	 et	 al.,	 2015;	 Varese	 et	 al.,	 2012;	 Walder,	 Faraone,	
Glatt,	Tsuang,	&	Seidman,	2014)	among	cannabis	use	(Murray	et	al.,	
2017)	and	urbanicity	(McGrath	et	al.,	2004;	Newbury	et	al.,	2018).	
In	addition,	recent	evidence	suggests	that	the	occurrence	of	ELS	
also	impacts	on	neurocognitive	function,	such	as	working	memory	
performance	in	both	individuals	with	PSY	and	HC	(Dauvermann	&	
Donohoe,	2019a;	Goodman,	Freeman,	&	Chalmers,	2019;	Vargas	
et	 al.,	 2019)	 as	 well	 as	 brain	 activation	 and	 connectivity	 in	 HC	
(Philip	 et	 al.,	 2016;	 Philip	 et	 al.,	 2013).	 However,	 little	 is	 known	
about the underlying mechanism between the environmental risk 
factor	 of	 ELS	 and	 working	 memory	 function	 in	 individuals	 with	
PSY.
The	 glutamate	 hypothesis	 of	 schizophrenia	 (Coyle,	 2012)	
and the N-methyl-D-aspartate	 receptor	 (NMDA-R)	hypofunction	
model	(Coyle,	1996)	posit	that	aberrant	glutamate	systems	(Krystal	
et	al.,	1994)	may	be	implicated	in	the	pathophysiology	of	schizo-
phrenia and psychosis. Proton magnetic resonance spectroscopy 
(1H-MRS)	 studies	 examined	 both	 the	 glutamate	 hypothesis	 of	
schizophrenia	and	the	NMDA-r	hypofunction	model	by	measuring	
resting-state glutamate levels in prefrontal brain regions in individ-
uals	with	SZ	and	BP.	Such	studies	reported	 inconsistent	findings	
of	glutamate	 levels	 in	the	dorsolateral	prefrontal	cortex	 (DLPFC)	
in	patients	with	SZ	(Poels	et	al.,	2014)	with	studies	reporting	(a)	in-
creased	glutamate	levels	(Olbrich	et	al.,	2008;	Rüsch	et	al.,	2008),	
(b)	decreased	glutamate	levels,	(Ćurčić-Blake	et	al.,	2017)	or	(c)	no	
difference	in	glutamate	levels	(Yoo	et	al.,	2009)	in	the	DLPFC	com-
pared	 to	 healthy	 controls	 (HC).	 For	 glutamate	 levels	 in	 the	ACC	
in	 patients	with	 SZ,	 there	 are	 further	 inconsistent	 findings	with	
the majority of studies demonstrating no difference in concentra-
tions	of	glutamate	or	glutamate-related	metabolites,	such	as	glu-
tamine	or	glutamate	and	glutamine	combined	(Glx)	concentrations	
between	 chronic	 patients	with	 SZ	 and	HC	 (Bustillo	 et	 al.,	 2011;	
Kraguljac,	Reid,	White,	Hollander,	&	Lahti,	2012;	Reid	et	al.,	2010;	
Rowland	 et	 al.,	 2013;	 Shirayama	 et	 al.,	 2010).	 However,	 a	 small	
number of studies also reported decreased concentrations of glu-
tamate	 between	 patients	with	 SZ	 and	HC	 (Tayoshi	 et	 al.,	 2009;	
Théberge	et	al.,	2003,	2004).	The	pattern	of	 findings	 in	patients	
with	BD	differs	from	patients	with	SZ,	where	individuals	with	BD	
consistently	showed	higher	Glx	levels	in	the	DLPFC	and	ACC	when	
compared	to	HC	(Öngür	et	al.,	2008;	Soeiro-de-Souza	et	al.,	2016).	
Focusing	on	working	memory	deficits,	 it	has	been	proposed	that	
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altered glutamate regulation is one of the main neurobiological 
pathways underlying working memory impairments in psychosis 
based	on	both	preclinical	and	clinical	evidence	(Dauvermann,	Lee,	
&	Dawson,	2017;	Dauvermann	et	al.,	2014;	Javitt,	2007).	Further	
support for the role of glutamate during working memory in indi-
viduals with PSY comes from a recent study using functional 1H-
MRS	(Jelen	et	al.,	2019).
In	 the	 last	 few	 years,	 emerging	 evidence	 proposes	 a	 role	 of	
stress,	 in	 particular	 social	 stress,	 in	 aberrant	 glutamatergic	 trans-
mission	 in	 the	 PFC	 in	 rodents	 (Schiavone	 et	 al.,	 2020;	 Zhang,	
Hernández,	Vázquez-Juárez,	Chay,	&	Barrio,	2016),	which	has	also	
been	 in	 shown	 in	 HC	who	 have	 experienced	 ELS	 (Duncan	 et	 al.,	
2015).	 Importantly,	 it	 has	 been	 shown	 that	 stress,	 in	 particular	
chronic	social	 stress,	 resulted	 in	both	deficits	 in	working	memory	
and	glutamatergic	dysregulation	 in	 the	PFC	 in	 rodents	 (Onaolapo	
et	al.,	2019;	Shao	et	al.,	2015;	Yuen	et	al.,	2011).	However,	to	date	
no	 study	 has	 examined	 the	 association	 between	 ELS	 experience	
and severity of psychotic symptoms in individuals with PSY when 
considering glutamate concentrations as a potential neurobiological 
mechanism,	 including	working	memory	function	 (Aas	et	al.,	2012;	
Janssen	et	al.,	2004).
1.1 | Aims of the study
In	 this	 study,	 we	 investigated	whether	 there	 is	 a	 relationship	 be-
tween	 the	experience	of	ELS	and	 severity	of	psychotic	 symptoms	
in	PSY.	In	addition,	we	examined	whether	working	memory	perfor-
mance and glutamate concentrations during resting state in the bi-
lateral	DLPFC	and	the	ACC	as	measured	with	1H-MRS	mediate	this	
relationship	between	the	ELS	experience	and	severity	of	psychotic	
symptoms.
2  | MATERIAL AND METHODS
2.1 | Participants
Forty-seven	participants	with	psychosis	(SZ	=	30,	BD	=	17)	and	41	
HC	were	recruited	for	the	study.	PSY	and	HC	were	recruited	from	
the	Royal	Edinburgh	Hospital,	associated	hospitals,	and	the	Scottish	
Mental	 Health	 Research	 Register	 (http://www.smhrn.org.uk/).	
Diagnosis	of	SZ	and	BD	was	based	on	interview	using	the	Structured	
Clinical	 Interview	 for	 DSM-IV	 (First,	 Spitzer,	 Gibbon	 &	 Williams,	
2002).	 Inclusion	criteria	 included	 (a)	diagnosis	of	established	SZ	or	
BD,	and	 (b)	no	acute	psychotic	 symptoms	at	 the	 time	of	 the	scan.	
Exclusion	criteria	included	(a)	history	of	any	major	psychiatric	illness	
other	than	SZ	or	BD,	(b)	history	of	severe	brain	injury,	(c)	history	of	a	
neurological	disorder,	and	(d)	dependency	or	harmful	use	of	alcohol	
or	drugs	during	the	last	12	months.	Also,	HC	were	excluded	if	they	
had	a	family	history	of	SZ	or	BD.	All	participants	provided	written	
informed consent. The study was approved by the local Research 
Ethics	Committee	(09/MRE00/81).
2.2 | Measures
2.2.1 | Demographic measures
Participants	provided	information	regarding	their	age,	sex,	and	ed-
ucation status. Participants were also asked regarding medication 
use	(antipsychotic	medication,	mood	stabilizers,	and	antidepressant	
medication).
Smoking status has not been recorded.
2.2.2 | Clinical measures
The	Positive	and	Negative	Syndrome	Scale	(PANSS;	Kay,	Fiszbein,	&	
Opler,	1987)	is	a	30-item	standardized	clinical	interview	to	rate	the	
presence and severity of positive and negative symptoms in PSY. 
The	measure	consists	of	 the	following	scales:	positive	symptoms,	
negative	symptoms,	general	symptoms,	and	total	score.	Items	were	
rescored	to	0	(“Absent”)	to	6	(“Extreme”)	for	symptoms	during	the	
past week with higher scores indicating greater severity. Internal 
reliability	 for	 the	 three	 subscales	of	positive	 symptoms,	negative	
symptoms,	and	general	symptoms	has	been	reported	as	adequate	
(Cronbach's α	.73–.83;	Kay	et	al.,	1987).	Previous	studies	have	indi-
cated	adequate	validity	of	the	PANSS	(Kay	et	al.,	1987).	Symptom	
rating took place within 1 week of the 1H-MRS	acquisition.
2.2.3 | Environmental questionnaires
The	Childhood	Life	Events	Questionnaire	(CLEQ;	http://bdrn.org/)	
is	 a	13-item	verbally	 administered	measure	of	ELS	 shared	by	 the	
Bipolar	 Disorder	 Research	 Network	 (BDRN	 [Upthegrove	 et	 al.,	
2015]).	All	participants	were	asked	whether	they	had	experienced	
any or all of a list of 12 adverse events prior to the age of 16 years as 
previously	reported	(Barker	et	al.,	2016;	Neilson	et	al.,	2017).	This	
list	includes	death	of	a	parent,	death	of	a	sibling,	death	of	a	friend,	
parental	separation,	parental	divorce,	admission	to	hospital,	hospi-
talization	of	parent,	visible	deformity,	teenage	pregnancy	or	father-
hood,	 imprisoned	parent	 and	 suspension	 from	school.	Responses	
ranged	 from	 0	 (“No”)	 to	 1	 (“Yes”).	While	 no	 questions	 regarding	
childhood	abuse	or	neglect	were	asked,	participants	were	given	the	
opportunity to provide this information by the final item which is an 
open-ended	question:	 “Are	there	any	other	significant	 life	events	
you	experienced	as	a	child	that	are	not	mentioned	above?”
2.3 | Working memory data
All	participants	performed	the	verbal	“2-back”	task.	They	were	pre-
sented	with	a	sequence	of	 single	capital	 letters.	The	experimental	
block	design	consisted	of	(a)	the	baseline	or	“0-back”	condition;	(b)	
the	 “1-back”	 condition;	 and	 (c)	 the	 “2-back”	 condition.	Full	 experi-
mental	details	are	presented	in	the	Appendix	S1.
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2.4 | Brain acquisition and analysis
2.4.1 | Structural MRI acquisition and analysis
Brain	scans	were	collected	using	a	3	T	Siemens	Verio	MRI	scanner	using	
a manufacturer-supplied 12-element matrix head coil at the Clinical 
Research	 Imaging	 Centre	 (CRIC),	 the	 Queen's	 Medical	 Research	
Institute,	 Edinburgh,	 UK.	 After	 a	 sagittal	 localizer,	 T1-weighted	
magnetization-prepared	rapid-acquisition	gradient	echo	(MPRAGE)	
MR	images	were	obtained	using	TR	=	2,300	ms,	TE	=	2.98	ms,	and	
TI	=	900	ms,	(flip	angle	=	9,	FOV	=	256	mm	×	256	mm)	with	an	iso-
tropic	voxel	resolution	of	1	mm,	parallel	to	AC-PC	plane.
2.4.2 | Proton magnetic resonance spectroscopy 
data acquisition and analysis
Magnetic resonance spectroscopy data acquisition
We	acquired	MRS	point-resolved	selective	spectroscopy	(PRESS)	spec-
tra	with	voxel	placements	in	the	ACC,	right	DLPFC,	and	left	DLPFC.	The	
voxels	were	shimmed	using	the	Siemens	advance	mode.	We	acquired	a	
water unsuppressed spectra with 16 averages and a water suppressed 
spectra	with	128	averages.	The	TE	was	set	to	80ms	and	the	TR	was	set	
to	3,000	ms.	The	phase	cycling	was	set	to	the	Siemens	16	EXOR-cycle	
mode	and	the	bandwidth	was	2,500	Hz	with	oversampling	enabled.	
The	voxels	in	the	DLPFC	measure	20	×	20	×	20	mm	(8	cm3)	and	in	the	
ACC	measures	30	×	20	×	15	mm	(9	cm3).
This	followed	a	standardized	protocol,	with	navigation	steps	to	
determine the coronal slice for placement. Cortical feature identifi-
cation	was	used	to	designate	the	voxel	center,	followed	by	rotations	
of the voxel in the transverse and sagittal views to obtain the final 
placement.	The	location	of	the	ACC	voxel	is	shown	in	Figure	1a	and	
the	placement	of	the	left	DLPFC	voxel	is	shown	in	Figure	1b.	Details	
for	the	voxel	placement	are	presented	in	the	Appendix	S1	and	in	a	
previous	paper	 (Thomson	et	al.,	2016).	An	example	of	a	spectrum	
acquired	in	the	dACC	in	a	HC	(Figure	1c).
Metabolite measurement
Spectral	 metabolite	 quantification	 was	 performed	 in	 LCModel	 ver-
sion	6.2	(http://www.s-prove	ncher.com/pages	/lcmod	el.shtml)	using	a	
gamma_press_te80_123mhz	basis	set	provided	at	http://s-prove	ncher	
-com	 for	 use	with	 the	 Siemens	 3T	Verio	 scanner.	 LCModel	 obtains	
maximum-likelihood estimates of metabolite concentrations and their 
uncertainties	 (Cramer–Rao	 lower	bounds;	CRLB).	The	quality	of	 the	
spectra obtained and the specificity of the measurement of a given 
metabolite	were	 evaluated	using	 the	CRLB	measure	of	 uncertainty.	
This is a measure of the specificity of the peak in the spectrum as-
sociated with a given metabolite. Only metabolite measurements that 
were	associated	with	a	fitting	error	(CRLB)	of	<15%	were	included	in	
the analysis.
The raw spectra were read into the graphical user interface for 
LCModel	and	processed	through	LC	Model	with	eddy	current	cor-
rection enabled and internal water reference was used to give the 
metabolite	in	institutional	units.	For	each	voxel	the	metabolite	val-
ues	derived	from	LCModel	were	corrected	for	voxel	cerebrospinal	
fluid	(CSF)	content	as	per	the	equation:
where	MetCI is the metabolite in institutional units and corrected for 
partial	 volume	 effects,	MetI is the internal water scaled metabolite 
value	given	by	LC	model,	and	FCSF	is	the	fractional	CSF	occupancy	of	
the	voxel.	The	fractional	CSF	volume	was	determined	from	the	seg-
mentation of the T1-weighted scan and the voxel placement and ro-
tation noted at scan time. The T1-weighted images were segmented 
into	gray	matter,	white	matter,	and	CSF	maps	using	SPM8	(Statistical	
Parametric	Mapping;	http://fil.ion.ucl.ac.uk/spm/).	The	CSF	volume	in	
each	voxel	was	extracted	using	a	c-script	that	sampled	the	SPM	seg-
mentation maps at the native space location noted for each voxel at 
time of scan.
2.5 | Statistical analysis
2.5.1 | Demographic data
Frequencies,	means,	and	standard	deviations	were	calculated	for	sex,	
age,	and	level	of	education	in	Statistical	Package	for	Social	Sciences	
version	25	(SPSS;	IBM,	2017).	Smoking	status	was	not	recorded.
2.5.2 | Clinical and environmental data
A	series	of	 t tests were conducted to examine differences between 
groups	 on	 measures,	 such	 as	 PANSS	 total	 scores,	 PANSS	 positive	
symptoms,	 PANSS	 negative	 symptoms,	 PANSS	 general	 scores,	 ELS	
data,	 and	 glutamate	 concentrations	 (separately	 in	 the	 right	 DLPFC,	
left	DLPFC,	 and	ACC).	 In	 following	 analyses,	 a	multivariate	ANOVA	
(MANOVA)	was	conducted	to	examine	group	differences	in	glutamate	
concentrations	in	the	bilateral	DLPFC	and	ACC.	Multiple	linear	regres-
sions	 assessed	whether	ELS	occurrences,	WM	performance,	 or	 glu-
tamate	metabolite	concentrations	 (separately	 in	 the	bilateral	DLPFC	
and	ACC)	predicted	psychotic	symptom	severity	by	introducing	these	
predictors systematically across blocks. Statistical significance was set 
at a p value below .05. Pearson's product-moment correlations were 
computed	to	examine	the	relationships	between	ELS	occurrence,	WM	
behavioral	 performance,	 glutamate	 metabolite	 concentrations,	 and	
psychotic symptom severity. p values were adjusted for multiple com-
parison	using	the	Hochberg	method	in	R	Studio	(RStudio	Team,	2018).
2.5.3 | Working memory data
Behavioral	 performance	 was	 calculated	 using	 the	 sensitivity	 index	
(d′)	 (Equation	1;	Macmillan,	Creelman,	&	Creelman,	2004).	Behavioral	
(1)MetCI=MetI×
(
1
1−FCSF
)
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performance	on	the	0-back,	1-back,	and	2-back	conditions	between	the	
groups was compared in SPSS using independent t	tests	and	ANOVAs.
2.5.4 | Glutamate concentrations
Analysis	 of	 covariance	 (ANCOVA)	was	 performed	 to	 examine	 the	
hypothesized	differences	in	glutamate	concentrations	in	each	region	
between	the	PSY	and	HC	groups.	Age	and	sex	were	entered	 in	as	
covariates for all comparisons.
3  | RESULTS
3.1 | Demographic, clinical, and working memory data
Demographic	and	clinical	data	are	presented	in	Table	1.	Ages	ranged	
from	 18	 to	 67	 years	 (M = 39.5,	 SD	 =	 12.99)	 with	 an	 average	 of	
(2)
d
�
= z
(
Hits
)
−z
(
FalseAlarms
)
z= statisticalZvalue
F I G U R E  1  Voxel	placement	and	example	of	magnetic	resonance	spectroscopy	spectrum.	(a)	Voxel	placement	for	the	anterior	cingulate	
cortex.	(b)	Voxel	placement	for	the	dorsolateral	prefrontal	cortex.	(c)	Example	for	glutamate	spectrum
(a)
(b)
(c)
6 of 13  |     CORCORAN et Al.
90	months	 of	 illness	 duration.	Most	 participants	 (55%)	 completed	
postsecondary education. The majority of participants who took 
part	in	the	study	were	male	(66.3%).	Demographic	and	clinical	data	
for	SZ	and	BD	subgroups	are	presented	in	the	Appendix	S1	(Table	S1).
3.1.1 | Clinical data
Psychotic symptom severity
Positive	and	Negative	Syndrome	Scale	severity	in	PSY	was	assessed	
with	comparable	severity	(Table	1).	In	addition,	independent	t tests 
revealed	a	significant	subgroup	difference	in	PANSS	positive	symp-
toms (t(45)	=	2.36,	p	=	.046,	d	=	0.76),	with	the	SZ	group	scoring	higher	
than	the	BD	group.	There	were	no	significant	group	differences	in	
PANSS	total	scores	(t(45)	=	0.945,	p	=	.220,	d	=	0.29),	PANSS	negative	
symptoms (t(45)	=	1.26,	p	=	.160,	d	=	0.42),	or	PANSS	general	symp-
toms (t(45)	=	−0.38,	p	=	.543,	d	=	0.66;	Table	S1).
3.1.2 | Early-life stress
The following reported experiencing no (n;	HC	=	15;	PSY	=	8),	one	
(HC	=	11;	PSY	=	6),	two	(HC	=	8;	PSY	=	6),	three	(HC	=	2;	PSY	=	10),	or	
four	or	more	(HC	=	3,	PSY	=	11)	occurrences	of	ELS.	Regarding	child-
hood	trauma	(i.e.,	abuse	and/or	neglect),	2.4%	of	HC	reported	such	
experiences,	compared	 to	12.2%	of	PSY	participants	 (SZ	=	13.3%,	
BD	=	11.7%).	An	independent	t	test	(PSY	vs.	HC)	revealed	a	signifi-
cant	group	difference	in	ELS	scores	(t(78)	=	3.29,	p	=	.001,	d	=	0.74)	
with PSY reporting greater occurrence (M	=	2.49,	SD	=	1.90)	than	HC	
(M	=	1.23,	SD	=	1.48).	A	one-way	ANOVA	(SZ	vs.	BD	vs.	HC)	revealed	
a	 significant	 subgroup	 difference	 in	 ELS	 scores	 (F(2,	 79)	 =	 6.729,	
p	=	 .002,	η2	=	 .149).	Post	hoc	analyses	revealed	a	significant	group	
difference	 between	 the	 HC	 and	 the	 SZ	 groups	 (p	 =	 .001)	 in	 ELS	
scores,	with	the	SZ	group	scoring	higher	(see	Table	S1).	There	was	
no	 significant	 group	 difference	 between	 the	 BD	 and	 HC	 groups	
(p	=	.267)	and	the	BD	and	SZ	groups	(p	=	.272)	on	ELS	scores.
3.1.3 | Working memory performance
To examine group differences in behavioral performance on the 
N-back	task,	a	series	of	t	tests	were	conducted	(HC	vs.	PSY).	There	was	
no significant difference on the 0-back performance (t(74)	=	1.622,	
p	=	.109,	d	=	0.372).	For	both	the	1-back	and	2-back	conditions,	PSY	
performed	less	accurately	than	HC.	Regarding	1-back	performance,	
there was a significant group difference (t(74)	 =	 3.212,	 p	 =	 .002,	
d	=	0.734),	with	the	PSY	group	(M	=	−0.60,	SD = 1.87)	scoring	lower	
than	the	HC	group	(M = 0.57,	SD = 1.26).	Regarding	2-back	perfor-
mance,	a	significant	group	difference	was	also	observed	(t(74)	=	2.60,	
p	=	.011,	d	=	0.594)	with	the	PSY	group	(M	=	−0.47,	SD = 1.70)	per-
forming	worse	than	the	HC	group	(M = 0.45,	SD = 1.38).
To	 examine	 any	 differences	 in	 N-back	 performance	 between	
subgroups,	 a	 series	of	one-way	ANOVAs	 (HC	vs.	 SZ	vs.	BD)	were	
conducted.	Regarding	behavioral	performance	on	the	0-back	 task,	
we did not find any significant differences between the three groups 
(F(2,76)	=	1.31,	p	=	.277,	η
2	=	.035).	Regarding	the	1-back	task,	a	sig-
nificant difference was observed (F(2,76)	=	5.121,	p	=	.008,	η
2	=	.123).	
Post	 hoc	 analyses	 revealed	 that	 the	 SZ	 group	 performed	 signifi-
cantly poorer (p	 =	 .012)	 than	 the	HC	group.	There	was	no	 signifi-
cant	difference	between	the	SZ	and	BD	groups	(p	=	.970)	or	the	BD	
and	HC	groups	 (p	=	 .092).	On	 the	2-back	 task,	 a	 significant	group	
difference was also found (F(2,76)	=	3.357,	p	=	.040,	η
2	=	.084).	Post	
hoc	analyses	revealed	that	the	SZ	group	scored	significantly	 lower	
(p	=	.049)	than	the	HC	group.	There	were	no	significant	differences	
 HC PSY Test p
N 41 47   
Age	Mean	(SD) 38.29	(14.44) 40.62	(11.63) t .406
Sex	(M:F) 23:18 33:14 χ2 .170
Education	(1:2:3)a  10:2:24 8:7:24 χ2 .112
PANSS	totalb 	Mean	(SD) – 23.28	(17.87) – –
PANSS	positiveb 	Mean	
(SD)
– 5.30	(5.00) – –
PANSS	negativeb 	Mean	
(SD)
– 6.38	(7.11) – –
PANSS	generalb 	Mean	
(SD)
– 11.60	(8.60) – –
CLEQc 	Mean	(SD) 1.23	(1.48) 2.49	(1.90) t .001*
Abbreviations:	CLEQ,	Childhood	Life	Events	Questionnaire;	HC,	healthy	controls;	PANSS,	Positive	
and	Negative	Symptom	Scale.
a0,	compulsory;	1,	more	than	compulsory;	2,	postsecondary.	
bRescaled	total	PANSS	scores.	
cRescaled	CLEQ	scores.	
*p	<	.001.	
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between	the	SZ	and	BD	groups	(p	=	.961)	or	between	the	BD	and	HC	
groups (p	=	.228).
3.2 | Glutamate concentrations
The	number	of	participants	who	met	the	criterion	of	data	quality	is	
presented	in	Table	2.	A	series	of	one-way	ANCOVAs	(PSY	vs.	HC)	
were conducted to examine whether glutamate concentrations in 
the	three	brain	areas	varied	according	to	group,	while	controlling	
for age and sex. The results of the testing found a significant differ-
ence	in	glutamate	concentration	in	the	left	DLPFC	between	groups	
(F(1,	63)	=	5.742,	p	=	.020,	partial	η
2	=	.084),	with	the	PSY	group	re-
porting	lower	concentrations	of	glutamate	than	the	HC	group	(see	
Table	2).	 There	were	no	 significant	differences	between	 the	PSY	
and	HC	groups	with	regards	to	glutamate	concentration	in	the	right	
DLPFC	(p	=	.324)	or	ACC	(p	=	.971).	Extension	of	the	inclusion	cri-
teria	(glutamate	standard	deviation	<30%)	resulted	in	no	significant	
difference	 in	 glutamate	 concentrations	 in	 the	 bilateral	DLPFC	 or	
ACC	 between	 the	 PSY	 and	HC	 groups	 (p	 >	 .05).	 These	 analyses	
were	repeated	for	subgroups	(SZ	vs.	BD	vs.	HC).	No	significant	dif-
ference	was	found	for	the	right	or	left	DLPFC	or	ACC	(see	Appendix	
S1;	Table	S2).
3.3 | Correlational analyses
Pearson's bivariate correlations were used to identify associations 
between	severity	of	clinical	symptoms,	ELS	occurrences,	glutamate	
concentrations	 (right	DLPFC,	 left	DLPFC	 and	ACC),	 and	WM	per-
formance	in	a	series	of	analyses.	First,	severity	of	clinical	symptoms	
and	occurrence	of	ELS	 in	PSY	only	were	 tested	 (Table	3).	Second,	
correlations	between	ELS	and	glutamate	concentrations	in	both	HC	
and PSY were run separately of each of the three brain regions (right 
DLPFC,	left	DLPFC	and	ACC;	Table	4).	Finally,	relationships	between	
ELS	 experience	 and	 WM	 performance	 were	 examined	 for	 both	
groups	 (Table	5).	p values were adjusted for multiple comparisons 
using	the	Hochberg	method.	The	α level was set at .05.
There were no significant correlations between the occurrence 
of	 ELS	 and	 severity	 of	 psychotic	 symptoms	 in	 the	 PSY	 group	 (all	
p	>	.05;	Table	3).	Regarding	glutamate	levels,	a	significant	negative	
correlation	between	the	occurrence	of	ELS	and	glutamate	concen-
tration	in	the	left	DLPFC	(r	=	−.449,	p	=	.029;	Table	4)	was	observed	
in	 the	HC	group	only.	 In	 the	PSY	group,	 there	were	no	significant	
correlations	between	the	occurrence	of	ELS	and	concentrations	of	
glutamate	in	the	right	DLPFC,	left	DLPFC,	or	ACC	(all	p >	.05).	We	
also did not observe any significant correlations between the occur-
rence	of	ELS	and	working	memory	performance	 in	 the	HC	or	PSY	
group (all p >	.05;	Table	5).
3.4 | Predictors of severity of psychotic symptoms
For	 the	 PSY	 group,	 occurrences	 of	 ELS,	 working	memory	 perfor-
mance and glutamate concentrations were systematically added 
across blocks in four multiple linear regressions predicting severity 
of	psychotic	 symptoms	 (PANSS	 total	 score,	PANSS	positive	symp-
toms,	 PANSS	 negative	 symptoms	 and	 PANSS	 general	 score).	 This	
process was repeated for glutamate concentrations in each of the 
three	brain	regions	(right	DLPFC,	left	DLPFC,	and	ACC).	No	model	
was predictive of psychotic symptoms (all p >	.05).
In	addition,	we	repeated	these	analyses	to	predict	the	relation-
ship	 between	 ELS,	working	memory,	 and	 psychotic	 symptoms	 for	
the	BD	and	SZ	groups	separately.	No	model	significantly	predicted	
symptoms	 in	 the	SZ	group	 (all	p >	 .05).	 In	patients	with	BD,	how-
ever,	the	model	that	included	2-back	working	memory	performance	
(β	=	−0.722)	significantly	predicted	negative	symptoms	(F(1,7)	=	6.531,	
p	=	.043),	explaining	44%	of	the	variance	of	negative	symptom	se-
verity scores. The same model (working memory β	 =	 −0.718)	 sig-
nificantly	predicted	PANSS	general	scores	(F(1,7)	=	6.370,	p	=	.045),	
explaining	43%	of	 the	variance.	No	other	model	was	predictive	of	
psychotic symptoms (all p >	.05).
3.5 | Multivariate analyses for psychotic symptom 
severity differences between clinical group and early-
life stress occurrences
To examine differences in psychotic symptom severity between 
both	clinical	groups	(SZ	and	BD)	and	ELS	experience,	reported	ELS	
experience	 was	 dichotomized	 into	 absent	 levels	 (e.g.,	 individuals	
who	reported	no	ELS	experience;	SZ	=	4,	BD	=	4)	and	present	levels	
(e.g.,	 individuals	who	reported	at	 least	one	event	of	ELS,	SZ	=	20,	
BD	 =	 13).	 A	 2	 x	 2	 design	 (SZ	 vs.	 BD	 and	 absent	 ELS	 vs.	 present	
ELS)	MANOVA	revealed	no	 interaction	effect	between	the	clinical	
groups	and	the	occurrence	of	ELS	 (Wilks'	λ	=	 .911,	F(4,	30)	=	1.145,	
p	=	.344,	partial	η2	=	.089).	While	a	significant	main	effect	for	clini-
cal group was found (Wilks' λ	=	.794,	F(3,	35)	=	3.021,	p	=	.043,	partial	
η2	=	 .206),	 there	was	no	significant	group	difference	 in	severity	of	
TA B L E  2  Glutamate	concentrations	in	institutional	units	(IU)a,b
 HC PSY Test p
R	DLPFC 8.64	(2.11)
n = 33
8.04	(1.46)
n = 29
F .324
L	DLPFC 8.20	(1.36)
n = 34
7.41	(1.37)
n = 33
F .020*
ACC 7.79	(1.71)
n	=	28
7.17	(1.87)
n = 35
F .971
Abbreviations:	ACC,	anterior	cingulate	cortex;	HC,	healthy	controls;	
L	DLPFC,	left	dorsolateral	prefrontal	cortex;	PSY,	individuals	with	
psychosis;	R	DLPFC,	right	dorsolateral	prefrontal	cortex.
aAge	and	sex	were	entered	as	covariates.	
bParticipants with glutamate concentration standard deviation 
exceeding	15%	were	excluded	from	this	table.	
*p	<	.05.	
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clinical	 symptoms	 for	 PANSS	 total	 scores,	 PANSS	 positive	 symp-
toms,	PANSS	negative	symptoms,	or	PANSS	general	symptoms	(all	
p >	 .05).	 There	was	 also	no	main	effect	 found	 for	ELS	experience	
(absent vs. present levels; Wilks' λ	=	.970,	F(3,	35)	=	0.355,	p	=	.786,	
partial η2	=	.030).
4  | DISCUSSION
The main aims of this study were to examine the association be-
tween	 the	occurrence	of	ELS	and	severity	of	psychotic	 symptoms	
in	PSY.	Furthermore,	we	studied	whether	glutamate	concentrations	
in prefrontal brain regions would mediate this relationship between 
ELS	experience	and	psychotic	symptom	severity.
One of the main findings was that patients with PSY experienced 
significantly	higher	occurrences	of	ELS	than	HC,	which	is	consistent	
with	previous	research	(Bailey	et	al.,	2018;	Varese	et	al.,	2012).	This	
finding	of	greater	prevalence	of	occurrences	of	ELS	in	PSY	compared	
to the general population is at the basis of gaining a better understand-
ing of the etiology of psychotic symptoms following the experience 
of	ELS	 (Barker,	Gumley,	Schwannauer,	&	Lawrie,	2015;	Chase	et	al.,	
2019;	Read,	Fosse,	Moskowitz,	&	Perry,	2014).	The	elucidation	of	this	
potential relationship has significant clinical and research implications 
for	improving	treatment	avenues,	such	as	pharmacological	treatment	
(based	on	altered	glutamate	concentrations)	or	cognitive	remediation	
trainings	 (based	 on	 altered	working	memory	 function).	 In	 our	 addi-
tional	analyses	focusing	on	both	SZ	and	BP,	we	found	that	SZ	reported	
higher	 ELS	 exposure	 when	 compared	 to	 HC,	 whereas	 BD	 showed	
comparable	 levels	 to	HC.	This	 latter	 finding	contrasts	previous	me-
ta-analyses,	which	suggested	that	ELS	occurrences	were	significantly	
higher	among	BD	compared	to	HC	(Etain	et	al.,	2010;	Macmillan	et	al.,	
2004).	 A	 possible	 reason	 for	 this	 discrepancy	 is	 the	 choice	 of	 ELS	
measure	of	the	CLEQ	in	this	study	when	compared	to	the	Childhood	
Trauma	Questionnaire	(CTQ)	among	others	(Dauvermann	et	al.,	2017).
Contrary	to	our	hypothesis,	the	occurrence	of	ELS	was	not	sig-
nificantly associated with the severity of psychotic symptoms in 
patients with PSY. This contrasts previous studies in which positive 
correlations between these two measures were revealed (Janssen 
et	 al.,	 2004;	Kay	 et	 al.,	 1987;	Öngür	 et	 al.,	 2008).	One	 reason	 for	
this	discrepancy	could	be	 the	 choice	of	ELS	measure	of	 the	CLEQ	
this	study.	Unlike	commonly	used	measures	of	childhood	trauma	or	
early-life	adversity,	such	as	the	CTQ	(Dauvermann	et	al.,	2017)	or	the	
Adverse	Childhood	Experiences	 (The	ACE	Score,	2003),	 the	CLEQ	
does not directly ask participants whether they have experienced 
abuse	 (e.g.,	 physical	 abuse)	or	neglect	 (e.g.,	 emotional	neglect)	but	
provides	 an	 open-ended	 question	 for	 such	 experiences	 to	 be	 re-
ported	 (“Are	 there	are	any	other	significant	 life	events	you	experi-
enced	as	a	child	that	are	not	mentioned	above?”).	This	open	question	
may have resulted in an under-reporting of abusive and neglectful 
experiences in this study. Support for this interpretation comes from 
a	previous	meta-analysis	which	reported	that,	dependent	on	adver-
sity	type,	between	26%	and	39%	of	participants	with	PSY	reported	
experiencing	trauma	as	a	child	(Bonoldi	et	al.,	2013).	However,	this	
figure	was	just	12.2%	for	individuals	with	PSY	in	this	study.	Despite	
the established association between childhood trauma and severity 
TA B L E  3   Pearson's correlation coefficients for severity of 
clinical symptoms and occurrence of early-life stress for individuals 
with psychosis
 PSY
N 41
PANSS scale
CLEQ scale
r p
Total .009 .996
Positive symptoms .011 .996
Negative	symptoms .052 .996
General symptoms −.030 .996
Abbreviations:	PANSS,	Positive	and	Negative	Symptom	Scale;	PSY,	
individuals with psychosis.
*denotes significant at p	<	.05.	
TA B L E  4   Pearson's correlation coefficients for glutamate 
concentrations and occurrence of early-life stress for healthy 
controls and individuals with psychosis
Brain region HC PSY
R	DLPFC
r −.088 −.045
p .703 .827
n 30 26
L	DLPFC
r −.449 .163
p .029* .577
n 31 31
ACC
r .131 .306
p .514 .089
n 27 32
Abbreviations:	ACC,	anterior	cingulate	cortex;	HC,	healthy	controls;	
L	DLPFC,	left	dorsolateral	prefrontal	cortex;	PSY,	individuals	with	
psychosis;	R	DLPFC,	right	dorsolateral	prefrontal	cortex.
*denotes significant atp	<	.05.	
TA B L E  5   Pearson's correlation coefficients for behavioral 
performance during working memory and occurrence of early-life 
stress for healthy controls and individuals with psychosis
 HC PSY
N 37 32
N-back r p r p
0-back −.343 .114 .025 .891
1-back −.050 .888 −.052 .888
2-back −.052 .921 .122 .921
Abbreviations:	HC,	healthy	controls;	PSY,	individuals	with	psychosis.
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of	psychotic	symptoms	(Agnew-Blais	&	Danese,	2016;	Bailey	et	al.,	
2018;	Bechdolf	et	al.,	2010;	Day	et	al.,	1987;	Gershon	et	al.,	2013;	
Holtzman	et	 al.,	 2013;	Lataster	et	 al.,	 2012;	Mayo	et	 al.,	 2017;	Os	
et	al.,	2010;	Shannon	et	al.,	2011;	Thompson	et	al.,	2009;	Üçok	et	al.,	
2015;	Varese	et	al.,	2012;	Walder	et	al.,	2014),	it	is	also	known	that	
other	environmental	risk	factors,	such	as	cannabis	use,	migration	and	
urbanicity	are	highly	correlated	with	psychosis	(Murray	et	al.,	2017;	
Neilson	et	al.,	2017;	Newbury	et	al.,	2018).	Recently,	it	has	been	sug-
gested	that	several	measurements	for	the	assessment	of	ELS	should	
be	used	to	cover	different	aspects	of	ELS	(Vargas	et	al.,	2019).
In	the	current	study,	ELS	experiences	were	not	significantly	as-
sociated with working memory performance despite finding that in-
dividuals	with	PSY	had	significantly	 increased	ELS	experience	and	
reduced	working	memory	performance	relative	to	HC.	These	group	
differences for both the low and high difficulty levels during working 
memory are consistent with meta-analyses and systematic reviews 
repeatedly	 confirming	 this	 (Forbes,	 Carrick,	 McIntosh,	 &	 Lawrie,	
2009;	 Frydecka	 et	 al.,	 2014;	Hamilton	 et	 al.,	 2009).	We	 speculate	
that	the	lack	of	a	significant	relationship	between	ELS	and	working	
memory in our study may be due to the working memory data uti-
lized.	 In	other	words,	 it	 is	possible	 that	 a	neurobiological	measure	
of working memory function in the form of blood-oxygen-level-de-
pendent	(BOLD)	response	of	brain	activity	as	measured	with	func-
tional	magnetic	resonance	imaging	(fMRI)	may	be	required	to	reveal	
a potential mediation role of reduced working memory function on 
the	relationship	between	ELS	and	severity	of	psychotic	symptoms.	
Support for this interpretation comes from inconsistently reported 
relationships	between	ELS	experience	 and	working	memory	 func-
tion	 across	 studies	 (Dauvermann	 &	 Donohoe,	 2019a;	 Goodman	
et	 al.,	 2019;	 Vargas	 et	 al.,	 2019)	 when	 behavioral	 performance	 is	
considered.	In	contrast,	widely	established	findings	of	altered	BOLD	
responses	of	the	DLPFC	in	individuals	with	PSY	when	compared	to	
HC	during	working	memory	 (Glahn	 et	 al.,	 2005;	Owen,	McMillan,	
Laird,	&	Bullmore,	2005)	emphasize	the	greater	reliability	to	study	
the	role	of	working	memory	on	the	severity	of	symptoms,	while	the	
laterality	of	the	DLPFC	underlying	working	memory	function	seems	
to	be	variable	across	studies.	In	addition,	a	recent	study	linking	glu-
tamate	concentrations	as	well	as	glutamate	+	glutamine	(Glx)	levels	
during a working memory task adds further support to the potential 
relevance of using brain function during working memory in indi-
viduals	 with	 psychosis	 (Jelen	 et	 al.,	 2019).	 Emerging	 evidence	 for	
utilizing	brain	activation	data	during	working	memory	to	study	this	
association	between	ELS	exposure	 and	working	memory	 also	em-
phasizes	the	recruitment	of	brain	activation	of	the	DLPFC	in	HC	with	
the	experience	of	childhood	trauma	(Philip	et	al.,	2013,	2016;	Teicher	
&	Samson,	2016;	Teicher,	Samson,	Anderson,	&	Ohashi,	2016)	and	
rodents	 following	 chronic	 stress	 exposure	 (Onaolapo	 et	 al.,	 2019;	
Shao	et	al.,	2015;	Yuen	et	al.,	2011).
Focusing	on	the	1H-MRS	data,	individuals	with	PSY	demonstrated	
significantly	 reduced	 glutamate	 concentrations	 in	 the	 left	 DLPFC	
compared	to	HC.	Previous	research	on	differences	in	glutamatergic	
neurotransmission	 (e.g.,	 glutamate,	Glx	 and	Gln	 concentrations)	 in	
BD,	SZ,	and	HC	has	produced	mixed	findings.	Studies	have	reported	
increased	Glx	concentrations	in	the	left	DLPFC	in	BD	relative	to	HC	
(Frey	et	al.,	2007;	Michael	et	al.,	2003;	Michael,	Erfurth,	&	Pfleiderer,	
2009;	Taylor,	2014),	but	significant	differences	in	Glx	between	indi-
viduals	with	SZ	 (regardless	of	medication	status)	and	HC	have	not	
been	observed	(Kaminski	et	al.,	2020).	Meta-analytical	research	has	
reported inconsistent findings between studies regarding glutamate 
concentrations	 in	 the	DLPFC	 (both	 right	 and	 left)	 in	patients	with	
SZ	 and	HC.	 Furthermore,	 there	were	 no	 significant	 differences	 in	
glutamate	 concentration	 in	 the	 right	DLPFC	or	ACC	 in	 individuals	
with	PSY	compared	to	HC.	Findings	from	previous	studies	in	these	
areas	are	also	inconsistent	(Marsman	et	al.,	2013;	Merritt,	Egerton,	
Kempton,	Taylor,	&	McGuire,	2016;	Poels	et	al.,	2014).	However,	a	
number of studies have found no evidence of group differences in 
glutamate,	glutamine,	or	Glx	concentrations	between	chronic	medi-
cated	patients	with	SZ	and	HC	(Bustillo	et	al.,	2011;	Kraguljac	et	al.,	
2012;	Reid	et	al.,	2010;	Rowland	et	al.,	2013;	Shirayama	et	al.,	2010). 
A	limitation	of	the	previous	research	is	that	many	studies	interpret	
glutamate,	Gln,	and	Glx	concentrations	interchangeably,	so	BD-	and	
SZ-related	increases	(Gigante	et	al.,	2012;	Théberge	et	al.,	2003)	that	
are	specific	to	one	of	these	indicators	(e.g.,	Gln	or	Glx)	but	not	others	
may	complicate	 the	picture.	Further	 research	 is	 required	to	better	
understand the roles of each of the glutamate-related metabolites in 
the	DLPFC	and	ACC	in	PSY.
Finally,	our	novel	findings	of	this	study	are	that	ELS	occurrences	
were inversely associated with glutamate concentrations in the left 
DLPFC	for	 the	HC	group	only.	Previous	studies	on	HC	focused	on	
the	effect	of	acute	stress	on	the	PFC,	with	reports	of	both	elevated	
Glx	concentrations	 (Zwanzger	et	al.,	2013)	and	no	change	 in	gluta-
mate	levels	(Houtepen	et	al.,	2017).	To	our	knowledge,	this	is	the	first	
study	providing	preliminary	evidence	of	 a	 link	between	ELS	expo-
sure	and	altered	glutamate	concentrations	in	the	DLPFC	in	humans,	
which is supporting impairments of glutamatergic neurotransmission 
previously	reported	in	rodents	after	chronic	social	stress	(Aas	et	al.,	
2012;	Janssen	et	al.,	2004).	However,	we	did	not	observe	a	signifi-
cant	relationship	between	ELS	experience	and	glutamate	concentra-
tions	in	individuals	with	PSY.	This	observed	association	in	HC	only	is	
comparable	to	a	stronger	relationship	between	the	experience	of	ELS	
and	deficits	in	neurocognitive	function	(including	working	memory)	
in	HC	than	in	individuals	with	PSY	(Malarbi,	Abu-Rayya,	Muscara,	&	
Stargatt,	2017;	Philip	et	al.,	2016;	Vargas	et	al.,	2019).	It	has	been	sug-
gested that such a finding could be due to the fact that the effect of 
ELS	cannot	be	isolated	from	other	known	implicated	factors	on	cog-
nitive	function	and	severity	of	psychotic	symptoms	in	PSY,	such	as	
genetic	risk	factors,	current	and	acute	stress	levels	(Dauvermann	&	
Donohoe,	2019b),	and	medication	effects	(Dauvermann	&	Donohoe,	
2019a;	Vargas	et	al.,	2019).	However,	given	the	strong	link	between	
ELS	and	increased	likelihood	of	developing	PSY	and	the	support	of	
aberrant	glutamatergic	 transmission	 in	 the	DLPFC	 in	PSY	 is	 it	 also	
possible that the lack of significant findings in individuals with PSY 
was	limited	by	methodological	shortcomings,	including	sample	size.
Future	 research	 studying	 relationships	 between	ELS,	 cognitive	
function,	and	neurobiological	markers	in	PSY	and	other	stress-sensi-
tive psychiatric disorders should focus on overcoming limitations of a 
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variety	of	neurocognitive	batteries	and	ELS	measures	(Dauvermann	
&	Donohoe,	2019a;	Vargas	et	al.,	2019)	 that	are	challenging	 to	 in-
terpret.	Emerging	evidence	on	combining	ELS,	cognitive,	endocrine,	
cytokine,	and	neuroimaging	data	will	lead	to	greater	insight	into	the	
interrelationships and therefore etiology of PSY.
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